These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8718615)

  • 1. An improved method for in vitro susceptibility testing of Trichomonas vaginalis.
    Bromke BJ; Furiga MC; Hendershot RC; McGinn M
    Adv Exp Med Biol; 1995; 390():211-6. PubMed ID: 8718615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro metronidazole susceptibility test for trichomoniasis using the InPouch TV test.
    Borchardt KA; Li Z; Zhang MZ; Shing H
    Genitourin Med; 1996 Apr; 72(2):132-5. PubMed ID: 8698362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of genotypes in relation to metronidazole susceptibility patterns in Trichomonas vaginalis isolated from South African pregnant women.
    Mabaso N; Abbai N
    Parasitol Res; 2021 Jun; 120(6):2233-2241. PubMed ID: 34002261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
    Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
    Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.
    Nix DE; Tyrrell R; Müller M
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1848-52. PubMed ID: 7486930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
    Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
    Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.
    Meri T; Jokiranta TS; Suhonen L; Meri S
    J Clin Microbiol; 2000 Feb; 38(2):763-7. PubMed ID: 10655382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
    Forbes GL; Drayton R; Forbes GD
    Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
    Schwebke JR; Barrientes FJ
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro.
    Elwakil HS; Tawfik RA; Alam-Eldin YH; Nassar DA
    Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on the in vitro susceptibility of Trichomonas vaginalis to metronidazole.
    Lin PR; Shaio MF
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Feb; 27(1):38-45. PubMed ID: 9747331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro sensitivity to metronidazole of Trichomonas vaginalis with isolates and clones.
    Sithithaworn P; Sithithaworn J; Kitjaroen K; Pairojkul C; Ratananurakpong S; Sriswangwonk T
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):279-84. PubMed ID: 2609217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
    Mammen-Tobin A; Wilson JD
    Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of metronidazole-resistant Trichomonas vaginalis.
    Goldman LM; Upcroft JA; Workowski K; Rapkin A
    Sex Health; 2009 Dec; 6(4):345-7. PubMed ID: 19917205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing vaginal trichomoniasis resistant to high-dose metronidazole therapy.
    Lewis DA; Habgood L; White R; Barker KF; Murphy SM
    Int J STD AIDS; 1997 Dec; 8(12):780-4. PubMed ID: 9433954
    [No Abstract]   [Full Text] [Related]  

  • 20. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
    Sobel JD; Nyirjesy P; Brown W
    Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.